Elevated serum levels of transforming growth factor β1 in Epstein-Barr virus-associated nasopharyngeal carcinoma patients

International Journal of Cancer

Volumn 84, Issue 4, 1999, Pages 396-399

  Xu, Jingwu ^a   Menezes, José ^a   Prasad, U ^b   Ahmad, Ali ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CANCER DIAGNOSIS; CANCER REGRESSION; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

EID: 0032802779     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0215(19990820)84:4<396::aid-ijc11>3.0.co;2-%23     Document Type: Article

References (20)

1. AHMAD, A. and MENEZES, J., Binding of the Epstein-Barr virus to human platelets causes the release of transforming growth factor-β1. J. Immunol., 159, 3984-3988 (1997).
2. ARVANITAKIS, L., YASEEN, N. and SHARMA, S., Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-β-1-mediated growth inhibition in EBV-positive B cells. J. Immunol., 155, 1047-1056 (1995).
3. BLOMHOFF, H.K., SMELAND, E., MUSTAFA, A.S., GODAL, T. and OHLSSON, R., Epstein-Barr virus mediates a switch in responsiveness to transforming growth factor, type beta, in cells of the B cell lineage. Europ. J. Immunol., 17, 299-301 (1987).
4. BORDER, W. A. and NOBLE, N.A., Targeting TGF-β for treatment of disease. Nature (Med.), 1, 1000-1001 (1995).
5. CAYROL, C. and FLEMINGTON, E.K., Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor beta igh3 (TGF-β igh3) and TGF-β1. J. Virol., 69, 4206-4212 (1995).
6. CHERRY, S.S. and HINSHAW, V.S., Influenza virus neuraminidase activates latent transforming growth factor β. J. Virol., 70, 8624-8629 (1996).
7. IVANOVIC, V., MELMAN, A., DAVIS-JOSEPH, B., VALCIC, M. and GELIEBTER, J., Elevated plasma levels of TGF-β1 in patients with invasive prostate cancer. Nature (Med.), 1, 282-284 (1995).
8. KADIN, M.F., CAVAILLÉ-COLL, M.W., GERTZ, R., MASSAGUÉ, J., CHEIFETZ, S. and GEORGE, D., Loss of receptors for transforming growth factor β in human T-cell malignancies. Proc. nat. Acad. Sci. (Wash.), 91, 6002-6006 (1994).
9. KONG, L.M., ANSCHER, M.S., MURASET, T., ABBOTT, D.A., IGLEHART, J.D. and JIRTLE, R.L., Elevated plasma transforming growth factor-β1 levels in breast cancer patients decrease after surgical removal of the tumor. Ann. Surg., 222, 155-162 (1995).
10. MARKOWITZ, S., WANG, J. and MYEROFF, L., Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science, 268, 1336-1338 (1995).
11. MASSAGUÉ, J., Receptors for the TGF-β family. Cell, 69, 1067-1070 (1992).
12. MOORE, K.W., O'GARA, A., DEWAAL-MALEFYT, R., VIERRA, P. and MOSSMANN, T.R., Interleukin 10. Ann. Rev. Immunol., 11, 165-190 (1993).
13. NOMORI, H., KAMEYA, T., SHIMOSATO, Y., SAITO, H., EBIHARA, S. and ONO, I., Nasopharyngeal carcinoma: immunohistochemical study for keratin, secretory component and leukocyte common antigen. Jpn. J. clin. Oncol., 15, 95-105 (1985).
14. RENZO, L.D., ALTIOK, A., KLEIN, G. and KLEIN, E., Endogenous TGF-β contributes to the induction of the EBV lytic cycle in Burkitt lymphoma cell lines. Int. J. Cancer, 57, 914-919 (1994).
15. SHIRAI, Y., KAWATA, S., TAMURA, S., ITO, N., TSUSHIMA, H. and TAKAISHI, K., Plasma transforming growth factor-β1 in patients with hepatocellular carcinoma: comparison with chronic liver diseases. Cancer, 73, 2275-2279 (1994).
16. SIXBEY, J.W. and YAO, Q.Y., Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science, 255, 1578-1580 (1992).
17. STRAVNEZER, J., Regulation of antibody production and class switching by TGF-β. J. Immunol., 155, 1647-1651 (1995).
18. TEO, P.M.L., TSAO, S.Y., HO, J.H.C. and YU, P., A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma. Radiol. Oncol., 21, 11-23 (1991).
19. VOKES, E.E., LEIBOWITZ, D.N. and WEICHSELBAUM, R.R., Nasopharyngeal carcinoma. Lancet, 350, 1087-1091 (1997).
20. ZHANG, Y., MUSCI, T. and DERYNCK, R., The tumor suppressor Smad4/ DPC4 as a central mediator of Smad function. Curr. Biol., 7, 270-276 (1997).